ArticleKidney diseases (Basel, Switzerland)
Genetic Susceptibility to Nephrolithiasis: A Genome-Phenome Approach with Polygenic Risk Score Analysis.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Kidney stone disease (KSD) is multifactorial, and the genetic basis is poorly understood among the East Asian population. This study aims to elucidate comprehensive genetic factors associated with KSD. Methods: We conducted a genome-wide association study (GWAS) on Taiwanese Han Chinese individuals from the Taiwan Biobank to investigate genetic predispositions to KSD. A total of 108,483 participants were included, of whom 7,635 reported having KSD. A phenome-wide association study (PheWAS) leveraging the National Health Insurance Research Database was used to verify GWAS findings and explore disease associations. We also assessed individual genetic risk for KSD using a polygenic risk score (PRS). Results: Our analysis identified significant associations with KSD at single-nucleotide polymorphisms rs1481012 (odds ratio = 1.13, Conclusion: This comprehensive study highlights the significant genetic contributors to KSD in an East Asian population. Our findings underscore the potential of using a national health database to validate our analyses and reveal novel disease correlations, which supported immune dysregulation in disease pathogenesis. PRS highlights the contribution of genetic variants to KSD risk and suggests potential for future clinical application, although validation in independent populations will be required to determine its predictive utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.